Company intelligence / Profile preview

Michael Allen Company

Darien, Connecticut, United Statescareers.usa.m3.com ↗

Ownership: Private
Development stage: Other

Overview

Michael Allen Company is a leading biopharma-focused consultancy with over four decades of experience. It specializes in sales, marketing, analytics, and research for pharmaceutical companies. The firm has worked with more than 85% of the top global pharma companies across over 100 therapeutic areas in more than 40 countries. In February 2023, it was acquired by M3 to expand M3’s global healthcare service offerings[1][2][3][4].

Industry: Consulting

Partnerships

Extensive relationships with top global pharmaceutical companies[1][2]

Beyond the preview

Go deeper on Michael Allen Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Michael Allen Company.

Explore the full profile